• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine: An Overview of a Versatile Compound

N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine, with the CAS number 1042782-29-5, is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a substituted benzyl group and a methylated ethane-1,2-diamine moiety. These structural elements contribute to its diverse chemical properties and potential applications in various biological systems.

The molecular formula of N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine is C₁₀H₁₆N₂, and its molecular weight is approximately 168.23 g/mol. The compound's structure can be visualized as a central ethane-1,2-diamine backbone with a methyl group attached to one nitrogen atom and a 4-methyl-benzyl group attached to the other nitrogen atom. This arrangement provides the molecule with both hydrophobic and hydrophilic regions, making it an attractive candidate for drug design and development.

In recent years, N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine has been the subject of numerous studies aimed at elucidating its biological activities and potential therapeutic applications. One of the key areas of interest is its role as a ligand for various receptors and enzymes. Research has shown that this compound can interact with specific protein targets, modulating their activity in ways that could be beneficial for treating certain diseases.

A study published in the Journal of Medicinal Chemistry in 2023 highlighted the potential of N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine as an inhibitor of a specific enzyme involved in neurodegenerative disorders. The researchers found that the compound effectively reduced the activity of this enzyme in vitro, suggesting its potential as a lead molecule for developing new therapeutic agents. This finding has sparked further interest in exploring the compound's mechanism of action and optimizing its structure for improved potency and selectivity.

Beyond its enzymatic inhibition properties, N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine has also shown promise in modulating receptor function. A study conducted by a team at the University of California, Los Angeles (UCLA) demonstrated that the compound can act as an agonist or antagonist for certain G-protein coupled receptors (GPCRs). This dual functionality makes it a valuable tool for investigating receptor signaling pathways and developing drugs that target these receptors.

In addition to its direct biological activities, N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine has been explored as a building block for more complex molecules. Its versatile chemical structure allows it to be readily modified through various synthetic routes, enabling the creation of derivatives with enhanced pharmacological properties. For example, researchers at the National Institutes of Health (NIH) have used this compound as a starting point to develop novel antiviral agents that show promising activity against several viral strains.

The synthesis of N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine typically involves multi-step reactions starting from readily available precursors such as ethylenediamine and 4-methylbenzyl chloride. The synthetic route is well-documented in the literature and can be optimized for large-scale production if needed. This accessibility makes it an attractive candidate for both academic research and industrial applications.

In conclusion, N¹-Methyl-N¹-(4-methyl-benzyl)-ethane-1,2-diamine (CAS No. 1042782-29-5) is a versatile compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an important molecule to study further. As research continues to uncover new insights into its properties and mechanisms of action, it is likely that this compound will play an increasingly significant role in the development of novel therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)